Kyowa Kirin Co. Ltd. Registered Shares o.N.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

1.41%

Market Cap

-

P/E Ratio

19.73

Dividend Yield

2.45 %

Earnings per Share

0.76 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE13.5 G0 Units
PRICE DETERMINATION TIME07/23/2026 / 09:56:25 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW13.813.5
PREV. DAY'S PRICE14 (07/22)
CHANGE DAY BEFORE
-0.50
-3.57 %
52 WEEK HIGH / LOW15.7 (02/27)11.5 (03/05)

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
1.000.690.760.790.98
DIVIDENDS PER SHARE
0.370.350.370.380.39
DIVIDEND YIELD IN %
2.36 %2.44 %2.45 %--
DIVIDEND GROWTH IN %
-0.55 %-4.08 %3.72 %--
PRICE - EARNINGS RATIO
15.6921.0119.7317.8014.37
PRICE - BOOK RATIO
1.521.461.48--
PRICE - SALES RATIO
2.882.542.66--
PRICE - CASH FLOW RATIO
11.0318.5313.69--
Further Key Figures

Master Data

WKN
858523
ISIN
JP3256000005
SYMBOL
KY4
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
KYOWA KIRIN CO. LTD.
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
1.45 %
2.94 %
9.38 %
0.72 %
-1.41 %
-18.13 %
-50.70 %
2.94 %
HIGH14.4014.7014.7015.7015.7020.8033.0015.70
LOW13.8013.2012.1011.5011.5011.5011.5011.50

Dividende

pro Aktie

Company profile

Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It handles the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension. It also produces and sells medical and industrial raw materials such as amino acids, nucleic acid-related compounds, and healthcare products. The company was founded by Benzaburo Kato on July 1, 1949 and is headquartered in Tokyo, Japan.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.